Systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurement
The present invention generally relates to systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurement. At least some of these enhanced BCG flow measurements can be used to address some surprising phenomena that may, at times, occur when wild stream blending therapeutic gas into breathing gas that a patient receives from a breathing circuit affiliated with a ventilator. Utilizing at least some of these enhanced BCG flow measurements the dose of therapeutic gas wild stream blended into breathing gas that the patient receives from a ventilator can at least be more accurate and/or over delivery of therapeutic gas into the breathing gas can be avoided and/or reduced.
1. A nitric oxide delivery system comprising:
an injector module for delivering a therapeutic gas into a breathing gas in a breathing circuit, the injector module comprising:
an injector body having a first opening and a second opening, the first opening and the second opening being configured to couple the injector module to the breathing circuit; and
a therapeutic gas inlet configured to receive the therapeutic gas and enable injection of the therapeutic gas into the breathing gas in the breathing circuit flowing through the injector module;
at least one sensor capable of measuring an amount of flow of the breathing gas in a forward direction and in a reverse direction; and
a control module for providing the therapeutic gas to the therapeutic gas inlet, and the control module being in communication with the at least one sensor and capable of determining a volume of forward flow and reverse flow of the breathing gas based on the measurements of the at least one sensor,
wherein the at least one sensor is part of or in fluid communication with the injector module, and the control module provides an alert if the control module determines that the injector module is improperly placed in the breathing circuit, and
wherein the therapeutic gas comprises nitric oxide.
2. The nitric oxide delivery system of claim 1 , wherein the control module determines that the injector module is improperly placed in the breathing circuit if the amount of reverse flow is greater than or equal to the amount of forward flow.
3. The nitric oxide delivery system of claim 2 , wherein if the amount of reverse flow is greater than the amount of forward flow, the control module determines that the injector module is placed in reverse and the control module switches the measurements for reverse flow and forward flow.
4. The nitric oxide delivery system of claim 1 , wherein the system further comprises an additional sensor capable of measuring humidity of the breathing gas, and the control module determines that the injector module is improperly placed in the breathing circuit if the relative humidity of the breathing circuit gas is above 60%.
5. The nitric oxide delivery system of claim 4 , wherein the additional sensor comprises humidity sensor and/or a thermal conductivity sensor.
6. The nitric oxide delivery system of claim 1 , wherein the system further comprises an additional sensor capable of measuring a temperature of the breathing circuit gas, and the control module determines that the injector module is improperly placed in the breathing circuit if the temperature of the breathing circuit gas is above 25° C.
7. The nitric oxide delivery system of claim 1 , wherein the system further comprises an additional sensor capable of measuring the temperature of the breathing circuit gas, and the control module determines that the injector module is improperly placed in the breathing circuit if the temperature of the breathing circuit gas is above 30° C.
8. The nitric oxide delivery system of claim 1 , wherein the system further comprises an additional sensor capable of measuring a type of gas in the breathing circuit gas, and the control module compensates delivery of therapeutic gas and/or provides an alert if the control module determines that the breathing circuit gas is not air or a mixture of air and oxygen.
9. The nitric oxide delivery system of claim 8 , wherein the additional sensor is capable of measuring the type of gas by measuring a density of the breathing gas and/or a thermal conductivity of the breathing gas.
10. The nitric oxide delivery system of claim 8 , wherein the control module selects a new flow calibration curve if the control module determines that the breathing circuit gas is not air or a mixture of air and oxygen.
11. The nitric oxide delivery system of claim 8 , wherein the control module prompts a user to enter a gas type if the control module determines that the breathing circuit gas is not air or a mixture of air and oxygen.
12. The nitric oxide delivery system of claim 8 , wherein the control module alerts a user to raise a fresh gas flow rate at or above a patient's minute ventilation if the control module determines that the breathing circuit gas includes anesthesia gases and/or a user indicates that the breathing circuit gas includes anesthesia gases.
13. The nitric oxide delivery system of claim 1 , wherein the at least one sensor is part of or in fluid communication with the injector module, and the control module receives information indicative of and/or determines a ventilator type.
14. The nitric oxide delivery system of claim 13 , wherein the control module determines the ventilator type based on information regarding the breathing gas.
15. The nitric oxide delivery system of claim 14 , wherein the control module determines the ventilator type is a BiPAP ventilator if the breathing circuit gas has one or more of (i) a low frequency and (ii) large volumes of reverse flow, and the control module prompts one or more of (i) a user to confirm the ventilator type, (ii) a user to enter a dead space volume, (iii) a user to add a carbon dioxide sensor to the breathing circuit, and (iv) the user whether or not to compensate for a patient airway dead space.
16. The nitric oxide delivery system of claim 14 , wherein the control module determines the ventilator type is a HFOV ventilator if the breathing circuit gas has one or more of (i) a high frequency, (ii) low volumes of reverse flow, (iii) high frequency forward flow pulses, and (iv) high common mode pressure, and the control module one or more of (i) prompts a user to confirm the ventilator type and (ii) delivers therapeutic gas ratiometrically to an average flow measured by a breathing circuit gas (BCG) flow sensor.
17. The nitric oxide delivery system of claim 14 , wherein if the control module determines the ventilator type is a conventional ventilator, the control module one or more of (i) prompts a user to confirm the ventilator type and (ii) delivers therapeutic gas ratiometrically to the flow measured by a breathing circuit gas (BCG) flow sensor.
18. The nitric oxide delivery system of claim 14 , wherein the control module determines the ventilator type by circuit pressure detection by using a gas injection tube in fluid communication with the therapeutic gas inlet as a pneumatic pressure sensing conduit.
19. The nitric oxide delivery system of claim 1 , wherein the system further comprises a carbon dioxide sensor, and the control module compensates for monitoring of the breathing gas and/or therapeutic gas delivery based on a measurement from the carbon dioxide sensor.